View Author
scopus: 54080768900

Schaik, E. van

( E. van Schaik)


patient insulinoma tumor treatment neuroendocrine metastatic hypoglycemia liver somatostatin receptor therapy pancreatic tumour insulin metastase control metastatic insulinomas octreotide journal month pancreas neuroendocrine tumors glucose everolimu tumours disease grade chemotherapy table study blood glucose levels liver metastases lymph diazoxide effect pancreatic neuroendocrine tumors cycle cancer herder response endocrinol diagnosis 8- wk intervals peptide receptor radiotherapy peptide radiolabeled somatostatin analogs endocrinology inhibitor /liter metastasi analog subtype oncology 5- fluorouracil doxorubicin metab pancreatic neuroendocrine tumours streptozocin carcinoma doxorubicin iv glucose sunitinib kwekkeboom interval medicine growth analogue somatostatin analogues radionuclide symptom ki -67 index european journal england journal activity survival episode ct scans endocrine-related cancer insulinoma pancreas sc octreotide radiolabeled




2 Most Recent Publications

Improved control of severe hypoglycemia in patients with malignant insulinomas by peptide receptor radionuclide therapy (Article)
Schaik, E. van Vliet, E.I. van Herder, W.W. de Feelders, R.A. Krenning, E.P. Khan, S. Kamp, K. Valkema, R. Nederveen, F.H. van Teunissen, J.J.M. Kwekkeboom, D.J.
2011-11-01
New therapeutic options for metastatic malignant insulinomas (Article)
Herder, W.W. de Schaik, E. van Kwekkeboom, D.J. Feelders, R.A.
2011-09-01